Compare, Analyse Orchid Chemicals with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs MYLAN (US) - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   MYLAN
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
MYLAN
Dec-18
ORCHID PHARMA LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1943,383-   
Low Rs351,862-   
Sales per share (Unadj.) Rs276.51,556.9-  
Earnings per share (Unadj.) Rs-79.242.3-  
Cash flow per share (Unadj.) Rs-43.5333.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.91,684.2-  
Shares outstanding (eoy) m70.45514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.41.7 24.6%   
Avg P/E ratio x-1.462.0 -2.3%  
P/CF ratio (eoy) x-2.67.9 -33.5%  
Price / Book Value ratio x2.11.6 136.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0671,349,457 0.6%   
No. of employees `0002.835.0 8.0%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.122,885.7 30.4%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.0621.4 -320.7%   
INCOME DATA
Net Sales Rs m19,477801,001 2.4%  
Other income Rs m4070-   
Total revenues Rs m19,884801,001 2.5%   
Gross profit Rs m1,103207,269 0.5%  
Depreciation Rs m2,519149,979 1.7%   
Interest Rs m5,22738,525 13.6%   
Profit before tax Rs m-6,23618,765 -33.2%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125-2,985 4.2%   
Profit after tax Rs m-5,58021,750 -25.7%  
Gross profit margin %5.725.9 21.9%  
Effective tax rate %2.0-15.9 -12.6%   
Net profit margin %-28.72.7 -1,055.1%  
BALANCE SHEET DATA
Current assets Rs m11,014447,278 2.5%   
Current liabilities Rs m32,060326,115 9.8%   
Net working cap to sales %-108.115.1 -714.4%  
Current ratio x0.31.4 25.0%  
Inventory Days Days9584 113.5%  
Debtors Days Days3493 36.0%  
Net fixed assets Rs m29,440155,381 18.9%   
Share capital Rs m705426 165.2%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,800866,536 0.4%   
Long term debt Rs m9,018935,271 1.0%   
Total assets Rs m46,5102,324,387 2.0%  
Interest coverage x-0.21.5 -13.0%   
Debt to equity ratio x2.41.1 219.9%  
Sales to assets ratio x0.40.3 121.5%   
Return on assets %-0.82.6 -29.3%  
Return on equity %-146.92.5 -5,850.6%  
Return on capital %-3.73.2 -117.5%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682166,448 1.0%  
From Investments Rs m-9,860-86,035 11.5%  
From Financial Activity Rs m6,644-77,541 -8.6%  
Net Cashflow Rs m-1,5351,379 -111.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare ORCHID PHARMA LTD With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA LTD With: UNICHEM LAB  PLETHICO PHARMA  ABBOTT INDIA  SUN PHARMA  AJANTA PHARMA  



Today's Market

Key Q2FY20 Results, BHEL Stake Sale, and Top Cues in Focus Today(Pre-Open)

On Friday, Indian share markets traded on a positive note most of the day and ended higher. The BSE Sensex logged total gains of 1,417 points in the past six sessions.

Related Views On News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS